Matthew T. Ballo, MD, Appointed Chair of the New Department of Radiation Oncology at UTHSC

Dr. Matthew Ballo has been appointed chair of the new Department of Radiation Oncology at UT Health Science Center

Dr. Matthew Ballo has been appointed chair of the new Department of Radiation Oncology at UT Health Science Center

David Stern, MD, executive dean of the College of Medicine at the University of Tennessee Health Science Center (UTHSC), has named Matthew T. Ballo, MD, chair of the newly formed Department of Radiation Oncology. [Read more...]

Ari VanderWalde, MD, Named Associate Vice Chancellor of Research – Clinical Trials at UTHSC

Clinical trials are scientific studies in which new treatments – drugs, diagnostic procedures, therapies, or preventive measures – are tested in patients to determine if they are safe and effective. Running successful clinical trials requires highly ethical, organized and experienced personnel. One such professional recently joined the University of Tennessee Health Science Center (UTHSC) in a newly created position. [Read more...]

Andrei V. Alexandrov, MD, Named Chair of the Department of Neurology and Semmes-Murphey Professor at UTHSC

Andrei Alexandrov, MD, has been named the new chair of Neurology and Semmes-Murphey Professor at UT Health Science Center.

Andrei Alexandrov, MD, has been named the new chair of Neurology and Semmes-Murphey Professor at UT Health Science Center.

David M. Stern, MD, executive dean of the College of Medicine at the University of Tennessee Health Science Center (UTHSC), has appointed Andrei V. Alexandrov, MD, as chair of the Department of Neurology and Semmes-Murphey Professor. [Read more...]

UTHSC Researchers Draw National Attention for Findings that Could Lead to Possible Treatment for Those with Most Severe Form of Multiple Sclerosis

Dr. Lidia Gardner and Dr. Michael Levin are researching Apolipoprotein A1, or ApoA1, and its relationship to Multiple Sclerosis.

Dr. Lidia Gardner and Dr. Michael Levin are researching Apolipoprotein A1, or ApoA1, and its relationship to Multiple Sclerosis.

Multiple sclerosis (MS) is a debilitating neurological disease that affects 2.3 million people worldwide, a number that has gone up 10 percent in the past five years. [Read more...]

College of Allied Health Sciences at UTHSC Invites Prospective Students to Open House on February 21

On Friday, Feb. 21, the College of Allied Health Sciences at the University of Tennessee Health Science Center (UTHSC) will host an open house for prospective students from 2 to 4 p.m. The college is searching for prospective students with required college-level prerequisites for its next classes in dental hygiene, physician assistant studies, physical therapy, occupational therapy, cytotechnology, histotechnology, medical technology, and health informatics and information management. [Read more...]

Chandra Alston, MBA, Named Associate Vice Chancellor of Human Resources for UTHSC

Chandra Alston ReducedKen Brown, JD, MPA, PhD, FACHE, executive vice chancellor and chief operations officer at the University of Tennessee Health Science Center (UTHSC), has named Chandra Alston, MBA, as the associate vice chancellor of Human Resources, effective immediately.  [Read more...]

Timothy Fabian, MD, Professor and Chair of Surgery at UTHSC to Step Down, National Search Planned for Successor

David Stern, MD, executive dean of the College of Medicine at the University of Tennessee Health Science Center (UTHSC), has announced that Timothy C. Fabian, MD, professor and chair of the UTHSC Department of Surgery, will step down from his position as chair once his successor has been named. [Read more...]

Professor Jonathan Wall Receives $1.58 Million Grant for Amyloid Disease Research

Dr. Jonathan Wall is exploring diagnostic and therapeutic agents for amyloid diseases. Dr. Wall has identified p5, a protein that binds to amyloid in the brain and other organs, making the amyloid visible through PET imaging and other techniques.

Dr. Jonathan Wall is exploring diagnostic and therapeutic agents for amyloid diseases. Dr. Wall has identified p5, a protein that binds to amyloid in the brain and other organs, making the amyloid visible through PET imaging and other techniques.

It is well known that patients with Alzheimer’s and other disorders, such as type 2 diabetes, develop amyloid, a substance composed of sticky protein fibers and sugar molecules that builds up in the brain or other organs in the body. Doctors do not know whether this material causes the diseases, or whether the diseases lead to amyloid formation. However, in less common diseases, such as light chain amyloidosis, a rare but devastating illness caused by the aggregation of antibody-related light chain proteins in organs such as the heart, liver, kidneys and spleen, there is no doubt that amyloid presence in the organs is the cause of the disease. [Read more...]